Discontinuation report OMNISCAN
Report ID | 182742 |
Drug Identification Number | 02172771 |
Brand name | OMNISCAN |
Common or Proper name | gadodiamide injection |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GADODIAMIDE |
Strength(s) | 287MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 mL |
ATC code | V08CA |
ATC description | MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2023-05-05 |
Actual discontinuation date | 2023-03-24 |
Remaining supply date | 2023-05-05 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-03-25 | English | Compare |
v4 | 2023-03-24 | French | Compare |
v3 | 2023-03-24 | English | Compare |
v2 | 2023-01-31 | French | Compare |
v1 | 2023-01-31 | English | Compare |
Showing 1 to 5 of 5